Citigroup Analyst Revises Price Target for ACADIA Pharmaceuticals
On March 12, 2024, Citigroup analyst David Hoang reiterated his positive outlook on ACADIA Pharmaceuticals (NASDAQ: ACAD) with a Buy ...
© 2024 Stocks Today
Tag: ACAD
Oppenheimer Analyst Reaffirms Perform Rating and 25 Price Target for ACADIA Pharmaceuticals
On February 5, 2024, Jay Olson, an analyst at Oppenheimer, restated his belief in ACADIA Pharmaceuticals (NASDAQ: ACAD) by giving ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape